Edgewell Personal Care(EPC) - 2026 Q1 - Earnings Call Transcript

Financial Data and Key Metrics Changes - The company reported a solid start to fiscal year 2026, with results modestly ahead of expectations, reflecting progress on its strategic focus areas [8][10] - Organic net sales decreased by 50 basis points, with North America showing strength that offset expected softness in international markets [10][22] - Adjusted EPS was reported at a loss of $0.16, compared to a loss of $0.10 in the prior quarter, while adjusted EBITDA was $25 million, down from $30.9 million in the prior year [27][28] Business Line Data and Key Metrics Changes - Organic net sales in North America grew just under 1%, driven by strong sun care performance, while Wet Shave organic net sales declined approximately 4% [22][24] - Sun and skincare organic net sales increased approximately 8%, with sun care growing nearly 20% in North America [24][25] - Grooming organic net sales growth was approximately 7%, led by significant growth in Cremo and Bulldog [24] Market Data and Key Metrics Changes - Over 70% of international markets either grew or held market share, with notable gains in Australia, Europe, Canada, and China [11][12] - In the U.S., market share pressure was modest, particularly in core Wet Shave, while men's grooming showed relative strength [10][11] - International Wet Shave organic net sales declined less than 1%, with volume declines partly offset by price gains [22] Company Strategy and Development Direction - The divestiture of the feminine care business is seen as a pivotal step in the company's transformation, allowing a sharper focus on core categories: shave, sun, skincare, and grooming [9][10] - The company aims to drive sustainable growth and stronger margins by reallocating capital and resources towards its core businesses [9][10] - The strategy includes a focus on international growth, innovation, productivity, and U.S. commercial transformation [12][18] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in returning to organic net sales growth, driven by mid-single-digit growth in international markets and a more stable performance in North America [19][20] - The company anticipates gross margin expansion supported by productivity gains, despite inflationary pressures [20][21] - Management highlighted the importance of disciplined capital allocation and the use of proceeds from the FemCare sale for debt reduction [35][36] Other Important Information - The company declared a quarterly dividend of $0.15 per share, returning approximately $7 million to shareholders [28] - Adjusted free cash flow is expected to be in the range of $80 million to $110 million for the year, driven by working capital discipline [35] Q&A Session Summary Question: Thoughts on portfolio construction post-FemCare divestiture - Management emphasized the strategic move to divest the FemCare business, which was growth dilutive and capital intensive, allowing for a sharper focus on core categories [39][40] Question: Expectations for fiscal Q2 organic sales - Management expects organic net sales to be down about 3% in Q2, primarily due to shipment timing and phasing impacts [50][51] Question: Implications for FemCare dilution into fiscal 2027 - Management indicated that while there will be stranded costs to address, the company is committed to right-sizing its overhead structure and expects a stronger portfolio moving forward [53][56] Question: Promotional levels in North America for Shave - Management acknowledged that promotional intensity remains high, particularly in women's shaving, but expressed confidence in improved trends as new distribution and innovation are implemented [82]